Effect of Fluvastatin on Progression of Coronary Atherosclerotic Plaque Evaluated by Virtual Histology Intravascular Ultrasound-Reference-Cited by-同舟云学术

Effect of Fluvastatin on Progression of Coronary Atherosclerotic Plaque Evaluated by Virtual Histology Intravascular Ultrasound

Published:2009-07 Issue:7 Volume:2 Page:689-696
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Nasu Kenya,Tsuchikane Etsuo,Katoh Osamu,Tanaka Nobuyoshi,Kimura Masashi,Ehara Mariko,Kinoshita Yoshihisa,Matsubara Tetsuo,Matsuo Hitoshi,Asakura Keiko,Asakura Yasushi,Terashima Mitsuyasu,Takayama Tadateru,Honye Junko,Hirayama Atsushi,Saito Satoshi,Suzuki Takahiko

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis;Nicholls;JAMA,2007

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

3. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial;Nissen;JAMA,2006

4. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial;Nissen;JAMA,2004

5. C-reactive protein levels and outcomes after statin therapy;Ridker;N Engl J Med,2005

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression;American Journal of Preventive Cardiology;2024-06

2. Drug intervention as an emerging concept for secondary prevention in patients with coronary disease;Cardiovascular Intervention and Therapeutics;2024-04-08

3. Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events;JAMA Cardiology;2023-10-01

4. Meta-analysis and trial sequential analysis of ezetimibe for coronary atherosclerotic plaque compositions;Frontiers in Pharmacology;2023-03-27

5. Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II;Circulation;2023-02-07